ReviewJournal of molecular and cellular cardiology2011

βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure.

Julio Cesar Batista Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.